Neurological complications in childhood nephrotic syndrome: A systematic review

被引:12
|
作者
Stabouli, Stella [1 ]
Chrysaidou, Katerina [1 ]
Kupferman, Juan C. [2 ]
Zafeiriou, Dimitrios I. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Paediat 1, Hippokratio Gen Hosp, Thessaloniki, Greece
[2] Maimonides Hosp, Dept Paediat, Brooklyn, NY 11219 USA
关键词
Nephrotic syndrome; Children; Sinovenous thrombosis; Stroke; Posterior reversible encephalopathy; REVERSIBLE ENCEPHALOPATHY SYNDROME; SAGITTAL SINUS THROMBOSIS; THROMBOEMBOLIC COMPLICATIONS; SINOVENOUS THROMBOSIS; VENOUS THROMBOSIS; RISK-FACTORS; CHILDREN; PATIENT; EPIDEMIOLOGY;
D O I
10.1016/j.ejpn.2019.02.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and objective: Nephrotic syndrome (NS) in childhood can be accompanied by serious neurological complications increasing the morbidity of disease. The study aimed to assess the spectrum of neurological complications in children with in terms of clinical presentation, contributory risk factors, and outcome. Methods: In this systematic review, we searched for articles in PubMed, providing individual patient-level data for any neurological complication in children and adolescents with primary NS, between January 1, 1990 and April 30, 2018. Findings: The search yielded 63 articles, involving 103 patients. Events occurred more frequently during nephrotic state relapses; 71.6% of cerebral thromboembolic (TE) events and 81.2% of posterior reversible encephalopathy (PRES) cases. Median duration of disease before a cerebral TE event was 3 months (IQR 0-27), and 18 months (IQR 1-37.5) for PRES. Among cases with TE, 73.1% presented with cerebral sinovenous thrombosis (CSVT), and 16.9% parenchymal lesions. 70% of patients had a risk factor for neurological complication including NS-associated thrombophilia, hypertension, and treatment with immunosuppressive agents. Outcome was favorable in 93.8% of the patients with PRES. In patients with cerebral TE outcome was favorable in 95.8% of the cases with CSVT only, and in 64.7% of the cases with parenchymal lesions. Conclusions: Neurological complications may occur in children with primary NS and risk factors during nephrotic state relapses. The outcome for PRES has been reported favorable. Outcome in cerebral TE events may differ by the presence of venous or artery infarct. Recognition of additional protrombotic state risk factors may help to lower the incidence of neurological complications. (C) 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:384 / 391
页数:8
相关论文
共 50 条
  • [41] Nephrotic syndrome associated with solid malignancies: a systematic review
    Liu, Shuo
    Wan, Yuchen
    Hu, Ziyu
    Wang, Zhixue
    Liu, Fenye
    BMC NEPHROLOGY, 2024, 25 (01)
  • [42] Neurological complications of childhood malignancies
    Tasdemiroglu, E
    Patchell, RA
    Kryscio, R
    ACTA NEUROCHIRURGICA, 1999, 141 (12) : 1313 - 1321
  • [43] Is rituximab effective in childhood nephrotic syndrome? Yes and no
    Kemper, Markus J.
    Lehnhardt, Anja
    Zawischa, Anna
    Oh, Jun
    PEDIATRIC NEPHROLOGY, 2014, 29 (08) : 1305 - 1311
  • [44] Emerging pharmacotherapies for the treatment of childhood nephrotic syndrome
    Salmon, Eloise
    Trachtman, Howard
    EXPERT OPINION ON PHARMACOTHERAPY, 2025,
  • [45] Histopathological spectrum of childhood nephrotic syndrome in Pakistan
    Muhammed Mubarak
    Ali Lanewala
    Javed Iqbal Kazi
    Fazal Akhter
    Atika Sher
    Amir Fayyaz
    Sajid Bhatti
    Clinical and Experimental Nephrology, 2009, 13 : 589 - 593
  • [46] The autoimmune architecture of childhood idiopathic nephrotic syndrome
    Al-Aubodah, Tho-Alfakar
    Piccirillo, Ciriaco A.
    Trachtman, Howard
    Takano, Tomoko
    KIDNEY INTERNATIONAL, 2025, 107 (02) : 271 - 279
  • [47] Levamisole and ANCA positivity in childhood nephrotic syndrome
    Krischock, Leah
    Pannila, Pasan
    Kennedy, Sean E.
    PEDIATRIC NEPHROLOGY, 2021, 36 (07) : 1795 - 1802
  • [48] Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome
    Ito, Shuichi
    Kamei, Koichi
    Ogura, Masao
    Udagawa, Tomohiro
    Fujinaga, Shuichiro
    Saito, Mari
    Sako, Mayumi
    Iijima, Kazumoto
    PEDIATRIC NEPHROLOGY, 2013, 28 (02) : 257 - 264
  • [49] Neurological Involvement in Childhood Evans Syndrome
    Pincez, Thomas
    Neven, Benedicte
    Le Pointe, Hubert Ducou
    Varlet, Pascale
    Fernandes, Helder
    Gareton, Albane
    Leverger, Guy
    Leblanc, Thierry
    Chambost, Herve
    Michel, Gerard
    Pasquet, Marlene
    Millot, Frederic
    Hermine, Olivier
    Mathian, Alexis
    Hully, Marie
    Zephir, Helene
    Hamidou, Mohamed
    Durand, Jean-Marc
    Perel, Yves
    Landman-Parker, Judith
    Rieux-Laucat, Frederic
    Aladjidi, Nathalie
    JOURNAL OF CLINICAL IMMUNOLOGY, 2019, 39 (02) : 171 - 181
  • [50] Zinc supplementation as an adjunct to standard therapy in childhood nephrotic syndrome-a systematic review
    Girish Chandra Bhatt
    Shikha Jain
    Rashmi Ranjan Das
    World Journal of Clinical Pediatrics, 2016, (04) : 383 - 390